Van de Westerlo Els: Difference between revisions

From Bioblast
(Created page with "{{Person |lastname=Van de Westerlo |firstname=Els |title=Ms. |institution= Radboud University Medisch Centrum Dept. of Medical BioSciences (MBS) |address=Geert Grooteplein 26...")
Β 
Β 
(3 intermediate revisions by one other user not shown)
Line 2: Line 2:
|lastname=Van de Westerlo
|lastname=Van de Westerlo
|firstname=Els
|firstname=Els
|title=Ms.
|title=
|institution=
|institution= [[File:Els van de Westerlo..jpg|right|180px|Van de Westerlo E]]Β  Radboud University Nijmegen Medical Centre
Radboud University Medisch Centrum
Dept. of Medical BioSciences (MBS)
Dept. of Medical BioSciences (MBS)


Line 16: Line 15:


== Participated at == Β 
== Participated at == Β 
::::* [[MiPNet28.02_IOC162_Schroecken_AT| IOC162 Schroecken AT]]


{{Labelingperson}}
{{Labelingperson}}

Latest revision as of 14:26, 16 October 2023

Name Van de Westerlo Els,
Institution
Van de Westerlo E
Radboud University Nijmegen Medical Centre

Dept. of Medical BioSciences (MBS)

Address Geert Grooteplein 26 (route 286), 6500
City Nijmegen
State/Province
Country NL
Email [email protected]
Weblink
O2k-Network Lab NL Nijmegen Koopman WJH


Participated at


Labels:



Publications

Add references to your publications

Abstracts

 PublishedReference
Koopman 2022 Abstract Bioblast20227.7. Β«10+5Β»
Koopman Werner
Bulthuis EP, Einer C, Distelmaier F, Groh L, van Emst-de Vries SE, van de Westerlo E, van de Wal M, Wagenaars J, Rodenburg RJ, Smeitink JAM, Riksen NP, Willems PGHM, Adjobo-Hermans MJW, Zischka H, Koopman Werner JH (2022) The decylTPP mitochondria-targeting moiety lowers electron transport system supercomplex levels in primary human skin fibroblasts. Bioblast 2022: BEC Inaugural Conference. In: https://doi.org/10.26124/bec:2022-0001 Β»Watch the presentationΒ«
Cookies help us deliver our services. By using our services, you agree to our use of cookies.